Anti-Therapeutic Action: reduced susceptibility to antifungal agents

Closing the diagnostic gap in medical mycology: The LODDY Test for identification of Lodderomyces elongisporus

Researchers developed a simple and affordable test called the LODDY Test to identify a dangerous yeast called Lodderomyces elongisporus that is often mistaken for a similar but less dangerous yeast. This test uses color changes on a special culture medium to distinguish between different yeast species in just 48 hours without expensive equipment. The test works perfectly in laboratories worldwide and could help doctors in developing countries diagnose and treat serious fungal infections more quickly and accurately.

Read More »

Insights into the structure, function, and impact of Candida albicans UPC2 gene on azole resistance; a mini-review

Candida albicans is a common fungal infection that doctors treat with azole medications, but the fungus is increasingly developing resistance to these drugs. Scientists have discovered that a gene called UPC2 plays a key role in this resistance by controlling the production of enzymes that help the fungus survive azole treatment. Understanding how UPC2 works could help develop new strategies to overcome drug-resistant fungal infections.

Read More »
Scroll to Top